LACTOLOGY FOUNDATION

ATC class A06AA comprises stool softeners (emollient laxatives) such as liquid paraffin and docusate sodium, which act locally in the gut to soften stools and are generally considered compatible with breastfeeding when used short term and at usual doses.medpedia.framar+3

Classification and members

The ATC group A06AA “Softeners, emollients” belongs to the anatomical main group A “Alimentary tract and metabolism” and the therapeutic subgroup A06 “Laxatives”.medpedia.framar
It includes emollient laxatives that soften and lubricate fecal material without significant systemic absorption.webmd+1

Key substances in A06AA are:wikipedia+2

·        A06AA01: Liquid paraffin (paraffinum liquidum, mineral oil) – used orally as a lubricant laxative.wikipedia+1

·        A06AA02: Docusate sodium – a surfactant stool softener that lowers stool surface tension.breastfeeding-and-medication+2

·        A06AA51: Liquid paraffin, combinations – fixed combinations of mineral oil with other laxatives or excipients.medpedia.framar

Mechanism of action

Emollient laxatives in A06AA primarily act within the intestinal lumen and are not significantly absorbed into the circulation.ncbi.nlm.nih+2
Liquid paraffin coats and lubricates the fecal mass and intestinal mucosa, facilitating passage of stool, whereas docusate sodium decreases surface tension and increases penetration of water and lipids into the stool, resulting in softer, easier-to-pass feces.breastfeeding-and-medication+2

By softening and increasing the moisture content of feces, these agents relieve constipation and reduce straining, which is particularly relevant in conditions where avoidance of increased intra-abdominal pressure is desirable (e.g. post‑partum, post‑surgery, hemorrhoids).breastfeeding-and-medication+1

Indications and clinical use

Drugs in A06AA are indicated for short‑term relief of constipation, especially when hard, dry stools cause pain or where straining should be minimized.mayoclinic+2
They are often used when non‑pharmacological measures (dietary fiber, fluids, physical activity) are insufficient, and may be chosen in postpartum and post‑operative patients or in individuals with anal fissures and hemorrhoids.droracle+2

Clinical guidelines generally recommend starting with lifestyle and bulk-forming or osmotic laxatives; stool softeners like docusate are used as adjuncts or second‑line options when stools remain hard.breastfeedingnetwork+2
Liquid paraffin and its combinations are used as lubricants but are usually reserved for short courses because of safety concerns with prolonged use.wikipedia+1

General safety profile (non‑lactation)

Emollient laxatives are usually well tolerated when used for brief periods, with the most common adverse effects being mild abdominal cramps, diarrhea and, rarely, nausea.mayoclinic+1
Liquid paraffin carries specific risks with chronic or inappropriate use, including leakage of oily stool, anal irritation, interference with absorption of fat‑soluble vitamins, and, if aspirated, lipoid pneumonia.wikipedia

Docusate sodium has a wide safety margin but should not be used at high doses or for prolonged periods because of the potential for electrolyte disturbances and dependency on laxatives.droracle+2
All A06AA agents should be used cautiously in patients with undiagnosed abdominal pain, intestinal obstruction, inflammatory bowel disease or acute surgical abdomen, and treatment should be stopped if rectal bleeding or failure to respond occurs.vinmec+2

Lactation pharmacology

Docusate sodium

Docusate is minimally absorbed from the gastrointestinal tract, so very little is expected to reach maternal serum or breast milk.ncbi.nlm.nih+1
Available lactation references conclude that, because of this poor systemic exposure, clinically relevant transfer to the breastfed infant is unlikely and significant adverse effects have not been documented.nhs+2

Clinical guidance (e.g. NHS advice and breastfeeding-specific resources) states that docusate can be used during breastfeeding, particularly for short-term treatment when dietary and lifestyle measures are insufficient, and it is not expected to cause side effects in the infant.sps+2
Nevertheless, routine recommendations emphasise using the lowest effective dose for the shortest duration and preferring non‑absorbed bulk-forming or osmotic laxatives as first‑line options.breastfeedingnetwork+2

Liquid paraffin (mineral oil)

Liquid paraffin is a highly refined mineral oil that is not significantly absorbed from the gut, so systemic exposure in the mother and transfer into milk after oral laxative use are expected to be low.e-lactation+1
Lactation-specific sources categorise paraffin-containing products as compatible with breastfeeding but advise limiting their use and avoiding application to the breast skin, or thoroughly removing residues before nursing, to minimise direct infant ingestion.pubmed.ncbi.nlm.nih+1

However, analytical studies have shown that mineral paraffins from cosmetic and breast‑care products can be detectable in human milk, and theoretical concern exists about long‑term exposure in infants.e-lactation+1
Consequently, many experts recommend non‑paraffin alternatives as first choice in breastfeeding women, reserving oral liquid paraffin for short‑term use when other options are unsuitable or ineffective.sps+2

Combinations containing liquid paraffin

For A06AA51 combinations, lactation safety depends on each component; the liquid paraffin part is considered of low risk when used briefly, while partner laxatives (e.g. stimulant agents) may have additional constraints.e-lactation+2
When assessing a specific combination product, both the mineral oil exposure and the pharmacokinetics of the co‑administered laxative should be considered, preferentially choosing formulations based on non‑absorbed agents with minimal infant exposure.droracle+1

Clinical recommendations in breastfeeding

In breastfeeding women with constipation, guidelines generally recommend:sps+2

·        First-line: non‑pharmacological measures (adequate dietary fiber and fluid intake, physical activity, bowel habit training).vinmec+2

·        Pharmacological first choice: non‑absorbed bulk‑forming or osmotic laxatives (e.g. ispaghula husk, macrogols, lactulose), which have minimal systemic absorption and are considered safe in lactation.droracle+2

·        Second-line / adjuncts: stool softeners such as docusate sodium, useful when stools remain hard despite first‑line measures, with short-term use and standard doses.nhs+2

Liquid paraffin and combination products may be used when other options are unsuitable but should be prescribed for limited durations, with attention to maternal risk (e.g. aspiration, fat‑soluble vitamin malabsorption) and minimisation of infant exposure from topical preparations.pubmed.ncbi.nlm.nih+2
Any laxative therapy in breast-feeding women should be reassessed if symptoms persist, if alarm signs such as rectal bleeding appear, or if the breastfed infant develops unexplained diarrhea, poor weight gain, or other gastrointestinal symptoms.mayoclinic+2